10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial.
Ontology highlight
SUBMITTER: DiNardo CD
PROVIDER: S-EPMC7549397 | biostudies-literature |
REPOSITORIES: biostudies-literature
ACCESS DATA